AI/MLDevelopersDevOpsNews

Integral Raises $6.9 Million To Maximize Data Privacy And Quality

funding, growth
0

Integral, a digital workflow management startup, has announced that it raised a $6.9 million seed round to protect sensitive health data and provide automated expert certification software that enables health and life sciences companies access to compliant, rich, de-identified data in hours, rather than months. The seed round was led by Haystack, The General Partnership, and Virtue Ventures, with additional support from Also Capital, Array Ventures, Caffeinated Capital, GreatPoint Ventures, LiveRamp Ventures, and Venrex.

Founded by Shubh Sinha, CEO and John Kuhn, CTO, Integral streamlines dataset creation by automating the de-identification and compliance certification process.

“Combining healthcare and non-healthcare data can transform healthcare research and innovation. John and I asked why healthcare companies couldn’t buy and analyze data as quickly as retailers like Target or Walmart, and we’ve made that possible with Integral. We’ve proven and will continue to prove that speed, accuracy, and privacy can be treated equally, even when working with highly regulated data,” said Sinha. “We created Integral to achieve this goal, ensuring personal information is protected and people’s privacy rights are respected. By prioritizing privacy and building trust with the public, researchers can unlock more value from data, which leads to better clinical trials, medications, products, technologies, and more.”

The company has already brought on highly experienced healthcare expert Timothy Nobles, who brings 18+ years of experience in large-scale, privacy-preserving data solutions in Healthcare and FinTech. Timothy will bolster commercial efforts as Integral broadens and scales go-to-business capabilities in its key markets and further develops proprietary platform capabilities with this new round of funding.

The company will soon announce the launch of its privacy analytics suite in conjunction with the team’s attendance at Pharma East 2023.